"Central Maine Eye Care specializes in medical and surgical treatment of eye diseases, while also providing routine vision care. Our Doctors are experienced in the treatment of cataracts, glaucoma, macular degeneration, diabetic retinopathy, corneal diseases, and retinal vascular disorders. We also prescribe eyeglasses, contact lenses, and have an onsite optical laboratory."

During the past decade, Central Maine Eye Care conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Maine Eye Care" #1 sponsor was "Kubota Vision Inc." with 2 trials, followed by "Aldeyra Therapeutics, Inc." with 1 trials sponsored, "BRIM Biotechnology Inc." with 1 trials sponsored, "Bausch & Lomb Incorporated" with 1 trials sponsored and "Eyegate Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Maine Eye Care" #1 collaborator was "Otsuka Pharmaceutical Co., Ltd." with 2 trials as a collaborator and "ORA, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Central Maine Eye Care" are "Dry Eye" (4 trials), "Dry Eye Syndrome" (4 trials), "Dry Eye Syndromes" (2 trials), "Keratoconjunctivitis Sicca" (2 trials) and "Blepharitis" (1 trials). Many other conditions were trialed in "Central Maine Eye Care" in a lesser frequency.

Most popular intervention types in "Central Maine Eye Care" are "Drug" (12 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "placebo eye drops" (2 trials), "rebamipide 2% ophthalmic suspension" (2 trials), "AzaSite®" (1 trials) and "BRM421" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Maine Eye Care" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Central Maine Eye Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Central Maine Eye Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Central Maine Eye Care, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".